Rapid death of injected myoblasts in myoblast transfer therapy

Muscle and Nerve

Volumn 19, Issue 7, 1996, Pages 853-860

  Fan, Ying ^a   Maley, Moira ^a   Beilharz, Manfred ^a   Grounds, Miranda ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

in situ hybridization; intramuscular injection; mdx mouse; myoblast transfer therapy; Y chromosome probe

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL FUSION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; IN SITU HYBRIDIZATION; MALE; MOUSE; MUSCLE FIBRIL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL COUNT; CELL MOVEMENT; CELL SURVIVAL; CELL TRANSPLANTATION; COLD; FEMALE; INJECTIONS, INTRAMUSCULAR; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; TIME FACTORS;

EID: 0029999201     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8     Document Type: Article

References (65)

1. Appleyard ST, Dunn MJ, Dubowitz V, Rose ML: Increased expression of HLA class 1 antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy and other neuromuscular disorders. Lancet 1985;16:361-363.
2. Askanas V, Engel WR: A new program for investigating adult human skeletal muscle grown in aneurally tissue culture. Neurology 1975;25:58-67.
3. Barr E, Leiden JM: Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 1991;254:1507-1509.
4. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA: Quantitative studies of the efficacy of myoblast transplantation. Muscle Nerve 1994;18(suppl 1):S261.
5. Beilharz MW, Garrett K, Fan Y, Fletcher S, Lareu R, Maley M, Vague M, Harvey A, Grounds MD: Genetic probes for tracking muscle precursor cells in vivo: Technical aspects, in Kakulas BA, Howell JMcC, Roses AD (eds): Duchenne Muscular Dystrophy: Animal Models and Genetic Manipulation. New York, Raven Press, 1992, pp 165-172.
6. Bischoff R: Enzymatic liberattio of myogenic cells from adult rat muscle. Anal Rec 1974;180:645-662.
7. Bulfield G, Siller WG, Wright PAL, Moore KJ: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81:1189-1192.
8. Cooper BJ, Gallagher EA, Smith CA, Valentine BA, Winand NJ: Mosaic expression of dystrophin in carriers of canine X-linked muscular dystrophy. Lab Invest 1990;62:171-178.
9. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM: Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 1991;254-1509-1512.
10. Emslie-Smith AM, Arahata K, Engel AG: Major histocompatibility class I antigen expression, immunolocalisation of interferon subtypes and T cell mediated cytotoxicity in myopathies. Hum Pathol 1989;20:224-231.
11. Fan Y, Beilharz MW, Grounds MD: A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts. Cell Transplant (in press).
12. Grounds MD, Lai MC, Fan Y, Codling JC, Beilharz MW: Transplantation in the mouse model - the use of a Y-chromosome-specific DNA clone to identify donor cells in situ. Transplantation 1991;52:1101-1105.
13. Guérette B, Asselin I, Vilquin JT, Roy R, Tremblay JP: Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995;18:39-51.
14. Gussoni E, Pavlath GK, Lancoto AM, Sharma KR, Miller RG, Steinman L, Blau HM: Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992;356:435-438.
15. Ham GR, St Clair JA, Webster C, Blau HM: Improved media for normal human muscle satellite cells: serum-free clonal growth with low serum. In Vitro Cell Dev Biol 1988;24:833-844.
16. Harvey AR, Fan Y, Beilharz MW, Grounds MD: Survival and migration of transplanted male glia in adult female mouse brains, monitored by a Y-chromosome-specific probe. Mol Brain Res 1992;12:339-343.
17. Hauschka SD: Clonal analysis of vertebrate myogenesis: II. Environmental influences upon human muscle differentiation. Dev Biol 1974;37:329-344.
18. Honda J, Rastami A: Expression of major histocompatibility complex class 1 antigens in rat muscle cultures. The possible developmental role in myogenesis. Proc Natl Acad Sci USA 1989;86:7009-7011.
19. Huard J, Ascadi G, Jani A, Massie B, Karpati G: Gene transfer into skeletal muscles by isogenic myoblasts. Hum Gene Ther 1994;5:949-958.
20. Huard J, Bouchard JP, Roy R, Halouin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP: Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992;15:550-560.
21. Huard J, Bouchard JP, Roy R, Labrecquet C, Dansereau G, Remieux B, Tremblay JP: Myoblast transplantation produces dystrophin-positive muscle fibres in a 16 year old patient with Duchenne muscular dystrophy. Clin Sci 1991;81:782-788.
22. Huard J, Roy R, Bouchard JP, Malouin F, Richards CL, Tremblay JP: Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 1992;24:3049-3951.
23. Huard J, Roy R, Guerette B, Verreault S, Tremblay G, Tremblay JP: Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 1994;17:224-234.
24. Hurko O, Hoffman EP, Mckere L, Johns DR, Kunkel LM: Dystrophin analysis in clonal myoblasts derived from a Duchenne muscular dystrophy carrier. Am J Hum Genet 1989;44:820-826.
25. Irintchev A, Zweyer M, Wernig A: Cellular and molecular reactions in mouse muscles after myoblast implantation. J Neurocytol 1995;24:319-331.
26. Jones GE, Murphy SJ, Watt DJ: Segregation of the myogenic cell lineage in mouse muscle development. J Cell Sci 1990; 97:659-667.
27. Jones PH: In vitro comparison of embryonic myoblasts and myogenic cells isolated from regenerating adult rat skeletal muscle. Exp Cell Res 1982;139:401-404.
28. Karpati G, Adjukovic D, Arnold D, Gledhill RB, Guttmann R, Holland P, Koch PA, Shoubridge E, Spence D, Vanasse M, Watters GV, Abrahamowicz M, Duff C, Warton RG: Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993;34:8-17.
29. Karpati G, Pouliot Y, Carpenter S: Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988;23:64-72.
30. Kinoshita I, Huard J, Tremblay JP: Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve 1994;17:975-980.
31. Kinoshita I, Vilquin JT, Guerett BG, Asselin I, Tremblay JP: Very efficient myoblast transplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-1415.
32. Kinoshita I, Vilquin JT, Tremblay JP: Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 1995;18:834-841.
33. Klamut HJ, Bosnoyan LO, Worton RG, Ray PN: Expression of human dystrophin mini gene in myogenic cell cultures, in Kakulas BA, Howell JMcC, Roses AD (eds): Duchenne Muscular Dystrophy: Animal Models and Genetic Manipulation. New York, Raven Press, 1992, pp 255-262.
34. Labrecque C, Roy R, Tremblay JP. Immune reactions after myoblast transplantation in mouse muscles. Transplant Proc 1992;24:2889-2892.
35. Law PK, Bertorini TE, Goodwin TG, Chen M, Fang QW, Li HJ, Kirby DS, Florendo JA, Herrod HG, Golden GS: Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy [letter]. Lancet 1990;336:114-115.
36. Law PK, Goodwin TG, Fang Q, Duggirala V, Larkin C, Florendo JA, Kirby DS, Deering MB, Li HJ, Chen M, Li LM, Yoo TJ, Cornett J, Li L, Shirzad A, Quinley T, Holcomb R: Feasibility, safety and efficacy of myoblast transfer therapy in Duchenne muscular dystrophy boys. Cell Transplant 1992;1:235-244.
37. Maley MA, Fan Y, Beilharz MW, Grounds MD: Intrinsic differences in MyoD and myogenin expression between primary cultures of SJL/J and Balb/c skeletal muscle. Exp Cell Res 1994;211:99-107.
38. McDonald RM, Dunn MJ, Dubowitz V: Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 1989;89:213-226.
39. McGeachie J, Grounds MD: Initiation and duration of muscle precursor cell replication after mild and severe injury to skeletal muscle. Cell Tissue Res 1987;248:125-130.
40. Mitchell CA, Grounds MD, Papadimitriou J: The genotype of bone marrow-derived inflammatory cells does not account for differences in skeletal muscle regeneration between SJL/J and BALB/c mice. Cell Tissue Res 1995;280:407-413.
41. Mitchell CA, McGeachie JK, Grounds MD: Cellular differences in the regeneration of murine muscle. A quantitative histological study in SJL/J and BALB/c mice. Cell Tissue Res 1992;269: 159-166.
42. Morgan JE: Cell and gene therapy in Duchenne muscular dystrophy. Hum Gene Therapy 1994;5:165-173.
43. Morgan JE, Hoffman EP, Partridge TA: Normal myogenic cells from newborn mice restore normal histology to regenerating muscles of the mdx mouse. J Cell Biol 1990;111:2437-2449.
44. Morgan JE, Moore SE, Walsh FS, Partridge TA: Formation of skeletal muscle in vivo from the mouse C2 cell line. J Cell Sci 1992;102:779-787.
45. Morgan JE, Pagent CN, Shercott T, Partridge TA: Long-term persistence and migration of myogenic cells injected into preirradiated muscle of mdx mice. J Neurol Sci 1993;115:191-200.
46. Morgan JE, Watt DJ: Myoblast transplantation in inherited myopathies. Mol Cell Biol Hum Dis Ser 1993;3:303-331.
47. Morgan JE, Watt DJ, Sloper JC, Partridge TA: Partial correction of an inherited defect of skeletal muscle by grafts of normal muscle precursor cells. J Neurol Sci 1988;86:137-147.
48. Nishioka Y: Application of Y-chromosome-specific repetitive sequences to sexing mouse embryos. Teratology 1988; 38:181-185.
49. Partridge TA: Myoblast transfer: a possible therapy for inherited myopathies? Muscle Nerve 1991;14:197-212.
50. Partridge TA, Grounds MD, Sloper JC: Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 1978;293:306-308.
51. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM: Conversion of mdx myofibers from dystrophin-negative to positive by injection of normal myoblasts. Nature 1989; 337:176-179.
52. Partridge TA, Morgan JE, Pagel CN, Coulton GR, Skynner MF, Coleman M, Watt DJ: Myoblast transplantation, in Kakulas BA, Howell JC, Roses AD (eds): Duchenne Muscular Dystrophy. Animal Models and Genetic Manipulation. New York, Raven Press, 1992, pp 175-188.
53. Phillips GD, Hoffman JR, Knighton DR: Migration of myogenic cells in the rat extensor digitorum longus muscle studied with a split autograft model. Cell Tissue Res 1990;262:8188.
54. Ponder BAJ, Wilkinson MM, Wood M, Westwood JH: Immunohistochemical demonstration of H2 antigens in mouse tissue sections. J Histochem Cytochem 1983;31:911-919.
55. Rando TA, Blau HM: Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 1994;125:1275-1287.
56. Richler C, Yaffe D: The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol 1970;23:1-22.
57. Robertson TA, Maley MA, Grounds MD, Papadimitriou JM: The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res 1993; 207:321-331.
58. Satoh A, Huard J, Labrecque C, Tremblay JP: Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasls. J Histochem Cytochem 1993;41:1579-1582.
59. Tremblay JP, Malouin F, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantation without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993;2:99-112.
60. Vilquin JT, Asselin I, Guerette B, Kinoshita I, Roy R, Tremblay JP: Successful myoblast allotransplantation in mdx mice using raparnycin. Transplantation 1995;59:422-446.
61. Watt DJ, Karasinski J, England MA: Migration of LacZ positive cells from the tibialis anterior to the extensor digitorum longus muscle of the X-linked muscular dystrophic (mdx) mouse. J Mus Res Cell Motil 1993;14:121-132.
62. Watt DJ, Karasinski J, Moss J, England MA: Migration of muscle cells. Nature 1994;368:406-407.
63. Wernig A, Irintchev A; "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J Neurol Sci 1995;130:190-196.
64. Wernig A, Irintchev A, Hartling A, Stephan G, Zimmerman K, Starzinski-Powetz A: Formation of new muscle fibers and tumours after injection of cultured myogenic cells. J Neurocytol 1991;20:982-997.
65. Yao SN, Kurachi K: Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc Natl Acad Sci USA 1992;89:3357-3361.